medication related osteonecrosis of the jaw (MRONJ), bisphosphonates, CT imaging


Medication-related osteonecrosis of the jaw (MRONJ) is a challenging condition for dental practitioners. Despite the plethora of published literature on this topic, widespread clinical awareness and recognition is still not common as clinicians still do not recognize the common, early presentations of this disease. This has been shown in different studies conducted in different parts of the world.1-4 The present paper highlights the important clinical considerations for practitioners to evaluate.